Rheumatoid arthritis

被引:33
|
作者
Diaz-Gonzalez, Federico [1 ,2 ,3 ]
Hernandez-Hernandeza, Maria V. [1 ]
机构
[1] Hosp Univ Canarias, Serv Reumatol, Tenerife, Spain
[2] Univ La Laguna, Dept Med Interna Dermatol & Psiquiatria, San Cristobal De La Lagun, Tenerife, Spain
[3] Univ La Laguna, Inst Univ Tecnol Biomed ITB, San Cristobal De La Lagun, Tenerife, Spain
来源
MEDICINA CLINICA | 2023年 / 161卷 / 12期
关键词
Rheumatoid arthritis; Etiopathogenesis; Treatment; Treat to target strategy; Disease activity; CITRULLINATED PEPTIDE ANTIBODIES; DISEASE-ACTIVITY SCORE; C-REACTIVE PROTEIN; CLASSIFICATION CRITERIA; CLINICAL-PRACTICE; AMERICAN-COLLEGE; DOUBLE-BLIND; ANTI-TNF; METHOTREXATE; MORTALITY;
D O I
10.1016/j.medcli.2023.07.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rheumatoid arthritis (RA) is a chronic inflammatory multisystemic disease of unknown etiology and autoimmune nature that predominantly affects peripheral joints in a symmetrical fashion. Although much progress has been made in understanding the pathophysiology of RA, its etiology remains unknown. Tumor necrosis factor (TNF)-a and interleukin (IL)-6 play the important roles in the pathogenesis and maintenance of inflammation in RA. The presence of anti-citrullinated peptide antibodies aids in the diagnosis in patients with undifferentiated polyarthritis and is associated with a more aggressive RA. The natural history of RA causes joint deformity and disability, as well as reduced life expectancy, both due to increased cardiovascular risk, pulmonary involvement, infections, iatrogenesis or tumors. Early diagnosis and the use of targeted drugs to induce early remission have improved the RA prognosis. (c) 2023 Elsevier Espana, S.L.U. All rights reserved.
引用
收藏
页码:533 / 542
页数:10
相关论文
共 50 条
  • [41] Recent advances in the treatment of rheumatoid arthritis
    Mahajan, Tina D.
    Mikuls, Ted R.
    CURRENT OPINION IN RHEUMATOLOGY, 2018, 30 (03) : 231 - 237
  • [42] Optimising low-dose methotrexate for rheumatoid arthritis-A review
    Lucas, Catherine J.
    Dimmitt, Simon B.
    Martin, Jennifer H.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 85 (10) : 2228 - 2234
  • [43] Comprehensive analysis of treatment response phenotypes in rheumatoid arthritis for pharmacogenetic studies
    Standish, Kristopher A.
    Huang, C. Chris
    Curran, Mark E.
    Schork, Nicholas J.
    ARTHRITIS RESEARCH & THERAPY, 2017, 19
  • [44] Biologic therapies for the treatment of rheumatoid arthritis
    Choi, Sung-Jae
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2021, 64 (02): : 95 - 104
  • [45] Rheumatoid arthritis
    Tanaka, Yoshiya
    INFLAMMATION AND REGENERATION, 2020, 40 (01)
  • [46] Repair of Erosions in Patients with Rheumatoid Arthritis
    Forslind, Kristina
    Eberhardt, Kerstin
    Svensson, Bjorn
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 670 - 675
  • [47] Rheumatoid arthritis
    Scott, David L.
    Wolfe, Frederick
    Huizinga, Torn W. J.
    LANCET, 2010, 376 (9746) : 1094 - 1108
  • [48] The "Treat to Target" Approach to Rheumatoid Arthritis
    Salomon-Escoto, Karen
    Kay, Jonathan
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2019, 45 (04) : 487 - +
  • [49] Immunogenicity of tocilizumab in patients with rheumatoid arthritis
    Sigaux, Johanna
    Hamze, Moustafa
    Daien, Claire
    Morel, Jacques
    Krzysiek, Roman
    Pallardy, Marc
    Maillere, Bernard
    Mariette, Xavier
    Miceli-Richard, Corinne
    JOINT BONE SPINE, 2017, 84 (01) : 39 - 45
  • [50] Rheumatoid arthritis: advances in treatment strategies
    Prasad, Peeyush
    Verma, Sneha
    Surbhi
    Ganguly, Nirmal Kumar
    Chaturvedi, Ved
    Mittal, Shivani Arora
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (01) : 69 - 88